Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
ADMA Biologics (ADMA)
NASDAQ:ADMA
ADMA Biologics (ADMA) Stock Price & Analysis
2,178 Followers
ADMA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.41 - $4.65
Previous Close$3.58
Volume1.77M
Average Volume (3M)2.09M
Market Cap
$805.16M
Enterprise Value$894.17M
Total Cash (Recent Filing)$62.51M
Total Debt (Recent Filing)$151.51M
Price to Earnings (P/E)-18.3
Beta0.33
Next Earnings
Nov 08, 2023EPS Estimate
>-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.20
Shares Outstanding224,906,426
10 Day Avg. Volume1,397,601
30 Day Avg. Volume2,093,905
Standard Deviation0.16
R-Squared0.08
Alpha-0.00230
Financial Highlights & Ratios
Price to Book (P/B)5.58
Price to Sales (P/S)13.39
Price to Cash Flow (P/CF)-32.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.30
Enterprise Value/Gross Profit25.36
Enterprise Value/Ebitda-64.02
Forecast
1Y Price Target
$6.00Price Target Upside67.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
ADMA Biologics News
Pre-EarningsADMA Earnings this Week: How Will it Perform?
Stock Analysis & Ideas‘Load Up,’ Says Raymond James About These 2 ‘Strong Buy’ Stocks
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADMA FAQ
What was ADMA Biologics’s price range in the past 12 months?
ADMA Biologics lowest stock price was $2.41 and its highest was $4.65 in the past 12 months.
What is ADMA Biologics’s market cap?
Currently, no data Available
When is ADMA Biologics’s upcoming earnings report date?
ADMA Biologics’s upcoming earnings report date is Nov 08, 2023 which is in 38 days.
How were ADMA Biologics’s earnings last quarter?
ADMA Biologics released its earnings results on Aug 09, 2023. The company reported -$0.018 earnings per share for the quarter, beating the consensus estimate of -$0.025 by $0.007.
Is ADMA Biologics overvalued?
According to Wall Street analysts ADMA Biologics’s price is currently Undervalued.
Does ADMA Biologics pay dividends?
ADMA Biologics does not currently pay dividends.
What is ADMA Biologics’s EPS estimate?
ADMA Biologics’s EPS estimate is >-$0.01.
How many shares outstanding does ADMA Biologics have?
ADMA Biologics has 224,906,430 shares outstanding.
What happened to ADMA Biologics’s price movement after its last earnings report?
ADMA Biologics reported an EPS of -$0.018 in its last earnings report, beating expectations of -$0.025. Following the earnings report the stock price went up 6.158%.
Which hedge fund is a major shareholder of ADMA Biologics?
Currently, no hedge funds are holding shares in ADMA
---
ADMA Biologics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (67.60% Upside)
$6.00 (67.60% Upside)
Blogger Sentiment
Bullish
ADMA Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $6.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.2%
Last 30 Days ▼ 1.8%
Last 30 Days ▼ 1.8%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.40%
12-Months-Change
Fundamentals
Return on Equity
-30.85%
Trailing 12-Months
Asset Growth
15.52%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ADMA Biologics
ADMA Biologics, Inc. operates as a biopharmaceutical company. It develops, manufactures, and intends to commercialize in human plasma and plasma-derived therapeutics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.
---
Top 5 ETFs holding ADMA
Vanguard Total Stock Market ETF
$24.68M
Vanguard U.S. Momentum Factor ETF
$519.61K
Schwab U.S. Broad Market ETF
$405.97K
iShares Russell 3000 ETF
$158.69K
Vanguard Russell 3000 ETF
$50.33K
Up to five ETFs with an Outperform Smart Score that hold ADMA. The ETFs are listed according to market value of ADMA within the ETF
---